• Mashup Score: 1

    Door-to-balloon (D2B) times for patients presenting with acute myocardial infarction (AMI) continue to lag as health care facilities struggle to recover from the COVID-19 pandemic, according to a study being presented at ACC Quality Summit 2023, kicking off Oct. 11 in Orlando, FL. Using CathPCI Registry data, Sara Belajonas, MSN, MBA, CCRN, APN-C, and Jeanne Jacobus, MSN, RN, from Ocean University Medical Center in Brick Township, NJ, identified a trend of climbing D2B times. The center averaged 60

    Tweet Tweets with this article
    • Using data from #CathPCIRegistry, researchers found door-to-balloon times for patients presenting w/ #cvAMI continue to lag as health care facilities struggle to recover from the #COVID19 pandemic. Read more: https://t.co/cunKKIGNsT #ACCQuality23 #NCDR https://t.co/8YRskCJpYE

  • Mashup Score: 3

    A long-standing expert roundtable discussion hosted by JACC Editor-in-Chief Valentin Fuster, MD, PhD, MACC, ACC Cardiology Hour provides key takeaways on top clinical trials released during cardiology’s most significant meetings. In the latest installment of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by expert panelists in a lively discussion on top late-breaking clinical trials released during the European Society of Cardiology Congress 2023. Watch for key takeaways and expert

    Tweet Tweets with this article
    • Catch up on top trials during #ESCCongress with ACC Cardiology Hour hosted by #JACC EiC Dr. Valentin Fuster. Watch the entire video or jump to discussions on COP-AF, MULTISTARS AMI, & more here: https://t.co/ZHHZG0WFKZ #ACCIntl #cvAMI #AFib #CardioTwitter https://t.co/Pvq3X71BUA

  • Mashup Score: 1

    In patients with acute MI complicated by cardiogenic shock, use of early extracorporeal life support did not reduce risk for death at 30 days compared with medical therapy alone, researchers reported.Early extracorporeal life support (ECLS), also known as venoarterial extracorporeal membrane oxygenation (VA-ECMO), did not improve 30-day death rates in this population in the ECLS-SHOCK trial or in

    Tweet Tweets with this article
    • #JACCCaseReports EiC Dr. @JGrapsa told @CardiologyToday the ELCS Shock findings for VA-ECMO use in #cvAMI/shock patients are "in contrast to the current guidelines and contrary to clinical practice. We need active discussion about this topic." https://t.co/1ysLncBejv #ESCCongress

  • Mashup Score: 9

    Early extracorporeal life support (ECLS) did not improve survival in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock who were scheduled for early revascularization, based on findings from the ECLS-SHOCK trial presented at ESC Congress 2023 and simultaneously published in the New England Journal of Medicine. Researchers randomized a total of 420 patients from 44 centers in Germany and Slovenia to either early ECLS plus usual medical treatment or to usual medical treatment

    Tweet Tweets with this article
    • Early ECLS did not 🚫 improve survival in patients with #cvAMI complicated by cardiogenic shock who were scheduled for early #revascularization in findings from ECLS-SHOCK presented at #ESCCongress. Were these results shocking? 🤯 https://t.co/w8LigPuypQ https://t.co/cXcewfLb6A